Peripheral Arterial Disease and Neuropathy Diagnosis and Management

Introduction to PAD and Neuropathy

The American Heart Association recommends that patients with bilateral calf pain and numbness in the feet be evaluated urgently for peripheral arterial disease (PAD), especially if they have diabetes, as this combination significantly increases amputation risk 1
The American College of Cardiology suggests that rest pain in the calf or foot that worsens when lying down and improves with leg dependency indicates critical limb ischemia (CLI) and requires same-day vascular specialist evaluation 1

The American Heart Association states that any skin breakdown, ulceration, or signs of infection (erythema, warmth, purulent discharge, fever) in patients with PAD mandates immediate systemic antibiotics and urgent vascular referral 1, 4
The American College of Cardiology recommends that patients with diabetes, neuropathy, chronic renal failure, or infection who develop acute limb symptoms be considered vascular emergencies 1

The American Heart Association recommends palpating and grading (0=absent, 1=diminished, 2=normal, 3=bounding) femoral, popliteal, dorsalis pedis, and posterior tibial pulses bilaterally to assess for PAD 1, 5
The American College of Cardiology suggests listening for femoral bruits indicating stenosis 1, 5

The American Academy of Neurology recommends performing 10-g monofilament testing at multiple plantar sites (balls of feet, toes), vibration testing with 128-Hz tuning fork, and ankle reflexes to assess for neuropathy 2
The American Diabetes Association suggests assessing temperature and pinprick sensation in both feet to evaluate small fiber function 2

The American Diabetes Association recommends ordering hemoglobin A1c or fasting glucose to identify diabetes, a major risk factor for PAD and peripheral neuropathy 2
The American Heart Association suggests ordering vitamin B12 level, as deficiency can cause sensory neuropathy 2

The American College of Cardiology recommends ankle-brachial index (ABI) as the first-line noninvasive test for suspected vascular disease 1, 5
The American Heart Association states that ABI <0.4 in non-diabetics or any diabetic with known PAD indicates high risk for CLI and requires regular foot inspection 1

The American College of Cardiology recommends supervised exercise therapy as the first-line treatment for PAD with claudication 4
The American Heart Association suggests a structured walking program that induces moderate claudication, performed 3 times weekly for at least 12 weeks 4
The American Diabetes Association recommends optimizing glycemic control (target HbA1c based on individual factors) for patients with diabetic neuropathy 2

The American Heart Association states that the combination of PAD and neuropathy significantly increases amputation risk and requires aggressive management 2
The American College of Cardiology recommends screening every 3-6 months for foot complications in patients with combined PAD and neuropathy 2